Sector News

Linde says more divestitures needed to get merger with Praxair approved

February 7, 2018
Chemical Value Chain

Linde said today that antitrust regulators are asking for more significant divestments than initially expected to get the $80 billion merger with Praxair approved.

“Discussions with various antitrust authorities have resulted in indications that merger clearance of the business combination of Linde [AG] and Praxair will be subject to requirements more onerous than previously assumed,” Linde said in a statement.

However, revenue and earnings of the required divestitures are not expected exceed a threshold that could result in termination of the deal. The merger agreement allows either party to terminate the deal if divestitures exceeding €1.1 billion/year ($1.4-billion) in EBITDA or €3.7 billion/year in revenue are required by regulators. Linde declined to comment on specifics.

“In the course of the antitrust proceedings in the European Union, Linde and Praxair will not submit final commitments to the European Commission in this first investigation phase (phase I). Therefore, the merger partners expect that the European Commission will initiate an in-depth investigation (phase II). When initiating a phase II investigation, the European Commission, in principle, decides within a period of 90 business days on the approval of the business combination,” Linde says, adding that a phase II investigation is not uncommon in large and complex transactions.

The timing to complete the deal has not changed. “Linde and Praxair will continue the constructive dialogue with antitrust authorities in order to complete the transaction in the second half of 2018,” Linde says. The combination will create the world’s largest industrial gases firm by revenue with pro forma 2016 revenue of about $32 billion before adjustments and potential divestitures.

By Natasha Alperowicz

Source: Chemical Week

comments closed

Related News

December 3, 2022

Corteva to acquire Stoller Group for $1.2 billion

Chemical Value Chain

Corteva (Indianapolis, Indiana) says it has signed a definitive agreement to acquire Stoller Group (Houston, Texas), a producer of biostimulants and plant nutrition products, for $1.2 billion. Stoller is one of the largest independent biologicals companies globally, with operations in more than 60 countries and more than $400 million in annual sales.

December 3, 2022

OMV introduces new corporate structure to drive sustainable growth and innovation

Chemical Value Chain

OMV has announced its new corporate structure today, designed to fully enable the delivery of Strategy 2030. The new organization will be built on five distinct areas. In addition to the CEO and CFO areas, three business segments will be established: Chemicals & Materials, Fuels & Feedstock, and Energy.

December 3, 2022

What does the current downturn in industrial manufacturing mean for executives searching for a senior role in the chemicals industry?

Chemical Value Chain

The European petchem sector is readying for some tough quarters. It’s a different picture in the US. So is this the best time ever to find a new role in the chemical industry? If you are in Europe, you would expect me to say probably not. But actually, it depends. So let me give you four answers to this question.